Trial Profile
Atorvastatin in patients with systolic heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Heart failure
- Focus Biomarker; Pharmacodynamics
- 11 Jan 2012 New trial record
- 07 Dec 2011 Results published in Clinical Therapeutics.